Skip to content

Increased expenditure on social security has benefits for TB control in the EU

Research for Prevention conference opens with real hope for an HIV vaccine

Second European PrEP study closes placebo arm early due to high effectiveness

How does a ‘human rights based approach’ work out on the ground? Lessons from South Africa

Emerging epidemic of transmitted HIV drug resistance in low- and middle-income countries, with highest burden seen in MSM

Bedaquiline as part of tailored therapy for MDR- and XDR-TB achieves impressive culture conversion rates

AbbVie 3D HCV regimen well-tolerated in PEARL trials

HIV care cascade at Kaiser Permanente varies by sex and age

Behavioural and financial incentives may improve HIV treatment outcomes